We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neurologic and Neurophysiologic Assessment of Clinical Course in Patients With Intraspinal Processes

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2010 by University of Zurich.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01105520
First Posted: April 16, 2010
Last Update Posted: April 16, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Zurich
  Purpose

Patients included in the study are treated at the Klinik für Neurochirurgie USZ. The clinical course is documented at Paraplegikerzentrum Balgrist using validated diagnostic procedures (e.g. SCIM, ASIA, neurophysiology).

Study aims:

Prognostic value of clinical diagnosis and additional diagnostic procedures? Which parameters exhibit optimal prognostic power? Differences between tumor/AVM associated lesions and traumatic lesions? What can we learn for pathophysiology and treatment?

  • Trial with surgical intervention

Condition Intervention Phase
Tumor Procedure: Diagnostic Phase 1

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by University of Zurich:

Estimated Enrollment: 100
Study Start Date: January 2010
Estimated Study Completion Date: December 2015
Groups/Cohorts Assigned Interventions
intralspinal processes
Patients with intralspinal processes
Procedure: Diagnostic
SCIM Spinal Cord Independence Measure ASIA scale American Spinal Injury Association

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients treated surgically for intraspinal processes
Criteria

Inclusion criteria:

  • Benign intraspinal process (tumor or vascular malformation AVM)
  • Primary lesion caudal of the brainstem, affecting C1
  • Cognitive ability to give written informed consent

Exclusion criteria:

  • Metastases, malign tumors
  • Traumatic lesions
  • Myelitis, polyneuropathy
  • Disc prolaps
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01105520


Contacts
Contact: 01 Studienregister MasterAdmins +41 (0)44 255 11 11

Locations
Switzerland
Recruiting
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

Responsible Party: Prof. H. Bertalanffy, University of Zurich
ClinicalTrials.gov Identifier: NCT01105520     History of Changes
Other Study ID Numbers: ZU-XYZ-003
First Submitted: April 15, 2010
First Posted: April 16, 2010
Last Update Posted: April 16, 2010
Last Verified: April 2010

Keywords provided by University of Zurich:
Intraspinal processes (tumor or vascular malformation AVM)


To Top